Report Library
All Reports
One Size No Longer Fits All: The Personalized Medicine Trial Landscape
May 31, 2017
Although the standard of care for a disease (when
one exists) generally has a well-established track
records, it’s a one-size-fits-all remedy that may
not be the best option for some patients. Medicine
is entering a new era as it becomes increasingly
personalized and the number of trials targeting
specific subsets of patient populations continue
to rise. The definition of “personalized medicine”
or “precision medicine” varies, and can refer
to an approach that incorporates insights on
environmental and behavioral factors, in addition
to a patient’s biology or genome, while informing
disease treatment or prevention. Some have a more
specific view – personalized medicine leverages
genetic profiles of patients to create tailored, more
targeted interventions to better treat or prevent
their conditions. This analysis will hone in on this
arm of personalized medicine, exploring the current
state of clinical research incorporating this strategy
into drug development, and the potential effect of
these approaches on the success of such trials.
Disease Group Covered: |
Infectious Disease
Neurology Oncology Respiratory |
Indications Covered: |
Castleman's Disease
Ischemic Stroke Premenstrual Dysphoric Disorder (PMDD) Smoking Cessation |
Additional Resources: